Home
Clene, Inc.

Clene, Inc. Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domainclene.com

Year Founded2013

Employees51 - 200

Annual Revenue< $1M

Clene, Inc.

Clene, Inc. (including company regionals)

clene.com

See more website traffic and engagement information

Total visits to Clene, Inc.'s top domains

Understand Clene, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

clene.com3.8K

See more with Sales Intelligence

Avg. visit duration in Clene, Inc.'s top domains

Analyze Clene, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

clene.com00:00:26

See more with Sales Intelligence

Avg. pageviews on Clene, Inc.'s top domains

See how Clene, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

clene.com1.99

See more with Sales Intelligence

Clene, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Clene, Inc.

These are the website technologies, by industry, used by Clene, Inc. top domains

Payment & Currencies (10)

Cart Functionality

Widget (6)

Twemoji

Advertising (5)

DoubleClick

eCommerce (5)

WooCommerce

More Technologies

11

See all

News & Signals from Clene, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsClene, Inc. will attend event 2026 Cantor Global Healthcare Conference on Sep 9th '26.SALT LAKE CITY, Sept. 03, 2026 (GLOBE NEWSWIRE) - Clene Inc. (Nasdaq: CLNN) today announced that management will present at the 2026 Cantor Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference and host 1x1 investor meetings at both conferences.

NewsClene, Inc. attended event Emerging Growth Conference on Aug 19th '26.Clene to present at the Emerging Growth Conference.

NewsClene, Inc. is developing nanotechnology-based therapeutics, including CNM-Au8 on Jul 16th '26.* Nano Dimension (NNDM) provides additive manufacturing and 3D printing systems, and Clene (CLNN) is developing clean-surfaced nanotechnology therapeutics, including its lead candidate CNM-Au8 in multiple clinical trials.